NHLBI Funding & Research Opportunities and Announcements for January 26, 2018

Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

            

Notices

Revised: Notice of NIH's Interest in Diversity
(NOT-OD-18-129) National Institutes of Health

Grant Application Due Dates Folowing the Receipt Lapse in Appropriations
(NOT-OD-18-131) National Institutes of Health

Notice of Correction to PA-18-517, "Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp - Clinical Trial Not Allowed)"
(NOT-CA-18-035)
National Cancer Institute

Request for Information (RFI): Strategically Critical Resources or Infrastructures Recommended for NHLBI Support Using the R24/U24 Grant Mechanisms
(NOT-HL-17-571)
National Heart, Lung, and Blood Institute

Notice of Correction of Key Dates for PAR-17-004 " Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)"
(NOT-HL-18-583)
National Heart, Lung, and Blood Institute

Notice of Expiration of RFA-HL-17-012 "Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44)"
(NOT-HL-18-584)
National Heart, Lung, and Blood Institute

NHLBI Announces Webinar for PAR-18-577, New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 - Clinical Trial Not Allowed)
(NOT-HL-18-587)
National Heart, Lung, and Blood Institute

Requests for Applications

The Human BioMolecular Atlas Program (HuBMAP) Integration, Visualization and Engagement (HIVE) Initiative (OT2 Clinical Trials Not Allowed)
(RFA-RM-18-001)
The Common Fund/Office of Strategic Coordination

Rodent Testing Centers for Development of Reporter Systems and Evaluation of Somatic Cell Genome Editing Tools (U42 Clinical Trial Not Allowed)
(RFA-RM-18-012)
The Common Fund/Office of Strategic Coordination

Development of Large Animal Reporter Systems for Testing Somatic Cell Genome Editing Tools (U24 Clinical Trial Not Allowed)
(RFA-RM-18-013)
The Common Fund/Office of Strategic Coordination

Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Gene Editing (U01 Clinical Trial Not Allowed)
(RFA-RM-18-015)
The Common Fund/Office of Strategic Coordination

Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed)
(RFA-RM-18-016)
The Common Fund/Office of Strategic Coordination

Expanding the Human Genome Editing Repertoire (U01 Clinical Trial Not Allowed)
(RFA-RM-18-017)
The Common Fund/Office of Strategic Coordination

Somatic Cell Genome Editing Dissemination and Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-RM-18-018)
The Common Fund/Office of Strategic Coordination

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
(PA-18-586)
National Heart, Lung, and Blood Institute

Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
(PA-18-589)
National Heart, Lung, and Blood Institute

Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
(PA-18-590)
National Heart, Lung, and Blood Institute

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)
(PA-18-591)
National Heart, Lung, and Blood Institute

Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed )
(PA-18-592)
National Institutes of Health

Program Announcements

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
(PA-18-586)
National Heart, Lung, and Blood Institute

Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
(PA-18-589)
National Heart, Lung, and Blood Institute

Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
(PA-18-590)
National Heart, Lung, and Blood Institute

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)
(PA-18-591)
National Heart, Lung, and Blood Institute

Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed )
(PA-18-592)
National Institutes of Health